Submit

Submit

Apply Icon

Projects Eligible for Consideration by LAB150

LAB150 is designed to support drug discovery and early preclinical development. The following types of projects are candidates for the program:

  • Critical Experiments to support final stages of target identification or validation
  • High throughput screening on targets of interest
  • Hit-to-Lead Generation
  • Testing novel therapeutic strategies in vitro and in vivo
  • Early ADME and DMPK

Who can apply

LAB150’s services are exclusively available to researchers, students or other affiliated staff within or connected to our member institutions.

If you have questions about your eligibility, please contact us.

Statement of Interest

  • Lead Investigator:

  • Name * Required
  • Collaborator(s)

  • List
    NameInstitutionAdd or remove row
    Add a new row
  • Project

  • Disease Area/Indication * Required
    (select all that apply)
  • Please include a brief description of the project, including target and rationale for pursuing it, mechanism of action, target disease indication and patient subsegments of interest (250 words or less).
  • Please include brief description of: current standard of care to manage target disease and patient segments; competitor approaches in clinical development; and competitive differentiation of proposed approach. (250 words or less)
  • Please include brief description of proposed experiments to achieve significant milestones (e.g. lead generation, lead optimization, pre-clinical POC, etc.) outlining lab's capabilities and gaps. (250 words or less)